BIOCELL2025，Vol.49Issue(8)：P.1505-1528,24.DOI:10.32604/biocell.2025.066504
The Effect and Mechanism of Thalidomide in Ameliorating Crohn’s Disease-Related Intestinal Fibrosis
Xiaoyue Feng 1Yu Liu 2Ying Kang 1Juan Wei 2Bei Yuan 3Kang Jiang 4Weijun Xu 2Xinyi Xia 5Fangyu Wang1
作者信息
- 1. Division of Gastroenterology and Hepatology,Nanjing Jinling Hospital,Jinling School of Clinical Medicine,Nanjing Medical University,Nanjing,210000,China
- 2. Division of Gastroenterology and Hepatology,Nanjing Jinling Hospital,Nanjing,210000,China
- 3. Pathology Department,Nanjing Jinling Hospital,Medical School of Nanjing University,Nanjing,210000,China
- 4. Division of Gastroenterology and Hepatology,Nanjing Jinling Hospital,Medical School of Nanjing University,Nanjing,210000,China
- 5. Institute of Laboratory Medicine,Nanjing Jinling Hospital,Medical School of Nanjing University,Nanjing,210000,China
- 折叠
摘要
关键词
Crohn’s disease/thalidomide/intestinal fibrosis/fibroblast分类
医药卫生引用本文复制引用
Xiaoyue Feng,Yu Liu,Ying Kang,Juan Wei,Bei Yuan,Kang Jiang,Weijun Xu,Xinyi Xia,Fangyu Wang..The Effect and Mechanism of Thalidomide in Ameliorating Crohn’s Disease-Related Intestinal Fibrosis[J].BIOCELL,2025,49(8):P.1505-1528,24.
